Douglas D. Boyd

University Of Texas Md Anderson Can Ctr

$4,994,999

Attributed

$4,994,999

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $779.5K · FY2005–10

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

Funding mix

By agency

NIH$4,994,999 · 4

By mechanism

R01$4,707,404 · 3

R56$287,595 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Xifeng Wu$28,679,533
J. Jack Lee$12,331,191
Scott M Lippman$54,535,308
Reuben Lotan$1,675,909
Jean-Pierre J Issa$21,637,643

Others in their field

Top investigators on “Urokinase”

Mortimer Poncz · University Of Pennsylvania$15,909,148
Lily Yang · Emory University$13,166,144
Nancy M. Dahms · Medical College Of Wisconsin$8,698,692
Steven L. Gonias · University Of California, San Diego$8,547,682
Jochen Reiser · Massachusetts General Hospital$7,362,427
Hui Mao · Emory University$6,424,860

Research focus

UrokinaseNeoplasm /Cancer InvasivenessHuman TissueReceptor ExpressionEnzyme Linked Immunosorbent AssayTissue /Cell CultureTranscription FactorWestern BlottingsGene ExpressionTransfectionNorthern BlottingsEnzyme InhibitorsProtein Tyrosine KinaseBinding (Molecular Function)Neoplastic CellDna Binding ProteinRegulationCancer CellBiological Signal TransductionColon NeoplasmsGenetic Promoter ElementProteinsColon CarcinomaImmunocytochemistry